These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. The Kir6.2-F333I mutation differentially modulates KATP channels composed of SUR1 or SUR2 subunits. Tammaro P; Ashcroft F J Physiol; 2007 Jun; 581(Pt 3):1259-69. PubMed ID: 17395632 [TBL] [Abstract][Full Text] [Related]
10. Interaction of K(ATP) channel modulators with sulfonylurea receptor SUR2B: implication for tetramer formation and allosteric coupling of subunits. Löffler-Walz C; Hambrock A; Quast U Mol Pharmacol; 2002 Feb; 61(2):407-14. PubMed ID: 11809866 [TBL] [Abstract][Full Text] [Related]
11. Pharmacological comparison of native mitochondrial K(ATP) channels with molecularly defined surface K(ATP) channels. Liu Y; Ren G; O'Rourke B; Marbán E; Seharaseyon J Mol Pharmacol; 2001 Feb; 59(2):225-30. PubMed ID: 11160857 [TBL] [Abstract][Full Text] [Related]
12. NMR and fluorescence studies of drug binding to the first nucleotide binding domain of SUR2A. López-Alonso JP; de Araujo ED; Kanelis V Biochemistry; 2012 Nov; 51(45):9211-22. PubMed ID: 23078514 [TBL] [Abstract][Full Text] [Related]
13. Effects of mitiglinide (S 21403) on Kir6.2/SUR1, Kir6.2/SUR2A and Kir6.2/SUR2B types of ATP-sensitive potassium channel. Reimann F; Proks P; Ashcroft FM Br J Pharmacol; 2001 Apr; 132(7):1542-8. PubMed ID: 11264248 [TBL] [Abstract][Full Text] [Related]
14. The novel diazoxide analog 3-isopropylamino-7-methoxy-4H-1,2,4-benzothiadiazine 1,1-dioxide is a selective Kir6.2/SUR1 channel opener. Dabrowski M; Ashcroft FM; Ashfield R; Lebrun P; Pirotte B; Egebjerg J; Bondo Hansen J; Wahl P Diabetes; 2002 Jun; 51(6):1896-906. PubMed ID: 12031979 [TBL] [Abstract][Full Text] [Related]
15. Different molecular sites of action for the KATP channel inhibitors, PNU-99963 and PNU-37883A. Cui Y; Tinker A; Clapp LH Br J Pharmacol; 2003 May; 139(1):122-8. PubMed ID: 12746230 [TBL] [Abstract][Full Text] [Related]
16. A functional role of the C-terminal 42 amino acids of SUR2A and SUR2B in the physiology and pharmacology of cardiovascular ATP-sensitive K(+) channels. Yamada M; Kurachi Y J Mol Cell Cardiol; 2005 Jul; 39(1):1-6. PubMed ID: 15978900 [TBL] [Abstract][Full Text] [Related]
17. Structural basis for the interference between nicorandil and sulfonylurea action. Reimann F; Ashcroft FM; Gribble FM Diabetes; 2001 Oct; 50(10):2253-9. PubMed ID: 11574406 [TBL] [Abstract][Full Text] [Related]
18. Sensitivity of KATP channels to cellular metabolic disorders and the underlying structural basis. Li CG; Cui WY; Wang H Acta Pharmacol Sin; 2016 Jan; 37(1):134-42. PubMed ID: 26725741 [TBL] [Abstract][Full Text] [Related]
19. Functional roles of cardiac and vascular ATP-sensitive potassium channels clarified by Kir6.2-knockout mice. Suzuki M; Li RA; Miki T; Uemura H; Sakamoto N; Ohmoto-Sekine Y; Tamagawa M; Ogura T; Seino S; Marbán E; Nakaya H Circ Res; 2001 Mar; 88(6):570-7. PubMed ID: 11282890 [TBL] [Abstract][Full Text] [Related]
20. The mutation Y1206S increases the affinity of the sulphonylurea receptor SUR2A for glibenclamide and enhances the effects of coexpression with Kir6.2. Stephan D; Stauss E; Lange U; Felsch H; Löffler-Walz C; Hambrock A; Russ U; Quast U Br J Pharmacol; 2005 Apr; 144(8):1078-88. PubMed ID: 15711591 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]